Predictors of Clinical Improvement in Rituximab-Treated Refractory Adult and Juvenile Dermatomyositis and Adult Polymyositis

OBJECTIVE: The aim was to identify the clinical and laboratory predictors of clinical improvement in a cohort of myositis patients treated with rituximab. METHODS: We analyzed data for 195 myositis patients [75 adult polymyositis/72 adult dermatomyositis/48 juvenile dermatomyositis (JDM)] in the Rit...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Aggarwal, Rohit, Bandos, Andriy, Reed, Ann M., Ascherman, Dana P., Barohn, Richard J., Feldman, Brian M., Miller, Frederick W., Rider, Lisa G., Harris-Love, Michael O., Levesque, Marc C., Oddis, Chester V.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2014
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3987896/
https://ncbi.nlm.nih.gov/pubmed/24574235
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/art.38270
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller